Skip to main content

Table 1 Summary of treatment outcome for cancer pets receiving electrochemotherapy

From: Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans

Drug Species N° of patients Tumor Type Response References
B Cats 12 STS SD 7 months 18
B Dogs and cats 16 Various 80% CR+PR 19
CDDP Dogs and cats 7 Various 84% CR 23
B Dogs and cats 5 Various CR > 24 mo 25
B Cats 58 STS Median time to recurrence: 12–19 mo 26
B Dogs 22 STS Median time to recurrence 24 mo 27
B Dogs 28 MCT 82%CR > 22 mo 28
B Cats 9 SCC 78%CR> 3 mo 29
B Cats 1 Ganglioneuroblastoma CR > 15 mo 30
B Dogs 10 Melanoma 70% CR> 6 mo 34
CDDP Dogs 1 Anal Melanoma PR 3 mo 35
B Dogs 12 Perianal tumors 83% CR 36
B Dogs and Cats 6 Lymphoma 100% CR 1 wk to 36 mo 37
B Cats 1 HPC CR> 12 mo 39
CDDP Dogs 1 Anal sac carcinoma CR> 18 mo 40
CDDP Cats 1 Fibrosarcoma CR 3 mo 41
Mitoxantrone Dogs 1 Metastatic carcinoma CR > 6 mo 43
  1. B Bleomycin; CDDP Cisplatin; CR Complete Remission; HPC Hemangiopericytoma; MCT Mast Cell Tumors; PR Partial Remission; SCC Squamous Cell Carcinoma; SD Stable Disease; STS Soft Tissue Sarcoma.